NCT05452278View on ClinicalTrials.gov

A Relative Bioavailability Study of Nicotine Delivery From Selected Oral Nicotine Products

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Healthy Volunteers
Interventions
OTHER

Product A

Tobacco-free pouch, 14 mg nicotine/pouch, used for 20 minutes

OTHER

Product B

Tobacco-free pouch, 16 mg nicotine/pouch, used for 20 minutes

OTHER

Product C

Tobacco-free pouch, 20 mg nicotine/pouch, used for 20 minutes

OTHER

Product D

Tobacco pouch, 16.6 mg nicotine/pouch, used for 20 minutes

Trial Locations (1)

SE-752 37

CTC Clinical Trial Consultants AB, Uppsala

All Listed Sponsors
lead

Imperial Brands PLC

INDUSTRY

NCT05452278 - A Relative Bioavailability Study of Nicotine Delivery From Selected Oral Nicotine Products | Biotech Hunter | Biotech Hunter